ID DCOR_MOUSE Reviewed; 461 AA. AC P00860; Q61997; Q61998; Q6PB87; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 27-MAR-2024, entry version 193. DE RecName: Full=Ornithine decarboxylase; DE Short=ODC; DE EC=4.1.1.17; GN Name=Odc1; Synonyms=Odc; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2982844; DOI=10.1016/s0021-9258(18)89457-1; RA Gupta M., Coffino P.; RT "Mouse ornithine decarboxylase. Complete amino acid sequence deduced from RT cDNA."; RL J. Biol. Chem. 260:2941-2944(1985). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=3856848; DOI=10.1073/pnas.82.6.1673; RA Kahana C., Nathans D.; RT "Nucleotide sequence of murine ornithine decarboxylase mRNA."; RL Proc. Natl. Acad. Sci. U.S.A. 82:1673-1677(1985). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=BALB/cJ; RX PubMed=3362685; DOI=10.1093/nar/16.6.2731; RA Coffino P., Chen E.L.; RT "Nucleotide sequence of the mouse ornithine decarboxylase gene."; RL Nucleic Acids Res. 16:2731-2731(1988). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=3372502; DOI=10.1016/s0021-9258(18)68541-2; RA Katz A., Kahana C.; RT "Isolation and characterization of the mouse ornithine decarboxylase RT gene."; RL J. Biol. Chem. 263:7604-7609(1988). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=8350350; DOI=10.1007/bf00556360; RA Johannes G.J., Berger F.G.; RT "Domains within the mammalian ornithine decarboxylase messenger RNA have RT evolved independently and episodically."; RL J. Mol. Evol. 36:555-567(1993). RN [6] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=Kunming; RA Yu Y., Luo X.; RL Submitted (APR-2008) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Egg; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [8] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [9] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Brain, and Embryo; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [10] RP NUCLEOTIDE SEQUENCE [MRNA] OF 178-461. RX PubMed=3456155; DOI=10.1073/pnas.83.3.594; RA Hickok N.J., Seppaenen P.J., Kontula K.K., Jaenne P.A., Bardin C.W., RA Jaenne O.A.; RT "Two ornithine decarboxylase mRNA species in mouse kidney arise from size RT heterogeneity at their 3' termini."; RL Proc. Natl. Acad. Sci. U.S.A. 83:594-598(1986). RN [11] RP PHOSPHORYLATION AT SER-303 BY CKII. RX PubMed=2026163; DOI=10.1111/j.1432-1033.1991.tb15927.x; RA Rosenberg-Hasson Y., Strumpf D., Kahana C.; RT "Mouse ornithine decarboxylase is phosphorylated by casein kinase-II at a RT predominant single location (serine 303)."; RL Eur. J. Biochem. 197:419-424(1991). RN [12] RP ACTIVE SITE, AND PYRIDOXAL PHOSPHATE AT LYS-69. RX PubMed=1730582; DOI=10.1016/s0021-9258(18)48472-4; RA Poulin R., Lu L., Ackermann B., Bey P., Pegg A.E.; RT "Mechanism of the irreversible inactivation of mouse ornithine RT decarboxylase by alpha-difluoromethylornithine. Characterization of RT sequences at the inhibitor and coenzyme binding sites."; RL J. Biol. Chem. 267:150-158(1992). RN [13] RP ACTIVE SITE. RX PubMed=8504104; DOI=10.1021/bi00073a017; RA Tobias K.E., Kahana C.; RT "Intersubunit location of the active site of mammalian ornithine RT decarboxylase as determined by hybridization of site-directed mutants."; RL Biochemistry 32:5842-5847(1993). RN [14] RP MUTAGENESIS OF GLY-387. RX PubMed=8243470; DOI=10.1111/j.1432-1033.1993.tb18371.x; RA Tobias K.E., Mamroud-Kidron E., Kahana C.; RT "Gly387 of murine ornithine decarboxylase is essential for the formation of RT stable homodimers."; RL Eur. J. Biochem. 218:245-250(1993). RN [15] RP SUBUNIT. RX PubMed=8106349; DOI=10.1016/s0021-9258(17)41842-4; RA Coleman C.S., Stanley B.A., Viswanath R., Pegg A.E.; RT "Rapid exchange of subunits of mammalian ornithine decarboxylase."; RL J. Biol. Chem. 269:3155-3158(1994). RN [16] RP FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=18973822; DOI=10.1016/j.biocel.2008.09.029; RA Lopez-Contreras A.J., Ramos-Molina B., Martinez-de-la-Torre M., RA Penafiel-Verdu C., Puelles L., Cremades A., Penafiel R.; RT "Expression of antizyme inhibitor 2 in male haploid germinal cells suggests RT a role in spermiogenesis."; RL Int. J. Biochem. Cell Biol. 41:1070-1078(2009). RN [17] RP FUNCTION, AND SUBUNIT. RX PubMed=24967154; DOI=10.1016/j.fob.2014.05.004; RA Ramos-Molina B., Lambertos A., Lopez-Contreras A.J., Kasprzak J.M., RA Czerwoniec A., Bujnicki J.M., Cremades A., Penafiel R.; RT "Structural and degradative aspects of ornithine decarboxylase antizyme RT inhibitor 2."; RL FEBS Open Bio 4:510-521(2014). RN [18] {ECO:0007744|PDB:7ODC} RP X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 1-424 IN COMPLEX WITH COFACTOR, RP AND PYRIDOXAL PHOSPHATE AT LYS-69. RX PubMed=10378276; DOI=10.1016/s0969-2126(99)80073-2; RA Kern A.D., Oliveira M.A., Coffino P., Hackert M.L.; RT "Structure of mammalian ornithine decarboxylase at 1.6 A resolution: RT stereochemical implications of PLP-dependent amino acid decarboxylases."; RL Structure 7:567-581(1999). CC -!- FUNCTION: Catalyzes the first and rate-limiting step of polyamine CC biosynthesis that converts ornithine into putrescine, which is the CC precursor for the polyamines, spermidine and spermine. Polyamines are CC essential for cell proliferation and are implicated in cellular CC processes, ranging from DNA replication to apoptosis. CC {ECO:0000269|PubMed:18973822, ECO:0000269|PubMed:24967154}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+) + L-ornithine = CO2 + putrescine; Xref=Rhea:RHEA:22964, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:46911, CC ChEBI:CHEBI:326268; EC=4.1.1.17; CC Evidence={ECO:0000250|UniProtKB:P11926}; CC -!- COFACTOR: CC Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; CC Evidence={ECO:0000269|PubMed:10378276, ECO:0000269|PubMed:1730582}; CC -!- ACTIVITY REGULATION: Inhibited by antizymes (AZs) OAZ1, OAZ2 and OAZ3 CC in response to polyamine levels. AZs inhibit the assembly of the CC functional homodimer by binding to ODC monomers. Additionally, OAZ1 CC targets ODC monomers for ubiquitin-independent proteolytic destruction CC by the 26S proteasome. {ECO:0000250|UniProtKB:P11926}. CC -!- PATHWAY: Amine and polyamine biosynthesis; putrescine biosynthesis via CC L-ornithine pathway; putrescine from L-ornithine: step 1/1. CC -!- SUBUNIT: Homodimer. Only the dimer is catalytically active, as the CC active sites are constructed of residues from both monomers CC (PubMed:8106349, PubMed:10378276). Does not form a heterodimer with CC AZIN2 (PubMed:24967154). {ECO:0000269|PubMed:10378276, CC ECO:0000269|PubMed:24967154, ECO:0000269|PubMed:8106349}. CC -!- TISSUE SPECIFICITY: Expressed during testis development in the outer CC part of the seminiferous tubules. {ECO:0000269|PubMed:18973822}. CC -!- SIMILARITY: Belongs to the Orn/Lys/Arg decarboxylase class-II family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M20617; AAA51638.1; -; mRNA. DR EMBL; M10624; AAA39845.1; -; mRNA. DR EMBL; X07392; CAA30301.1; -; Genomic_DNA. DR EMBL; J03733; AAA39849.1; -; Genomic_DNA. DR EMBL; S64539; AAB27809.1; -; mRNA. DR EMBL; EU684749; ACD81645.1; -; mRNA. DR EMBL; AK139610; BAE24082.1; -; mRNA. DR EMBL; CH466582; EDK98494.1; -; Genomic_DNA. DR EMBL; BC059826; AAH59826.1; -; mRNA. DR EMBL; BC083122; AAH83122.1; -; mRNA. DR EMBL; M12330; AAA39846.1; -; mRNA. DR EMBL; M12331; AAA39848.1; -; mRNA. DR CCDS; CCDS25829.1; -. DR PIR; A01077; DCMSO. DR PIR; I56477; I56477. DR RefSeq; NP_038642.2; NM_013614.2. DR RefSeq; XP_017170479.1; XM_017314990.1. DR PDB; 7ODC; X-ray; 1.60 A; A=1-424. DR PDBsum; 7ODC; -. DR AlphaFoldDB; P00860; -. DR SMR; P00860; -. DR BioGRID; 201896; 1. DR IntAct; P00860; 1. DR STRING; 10090.ENSMUSP00000128661; -. DR ChEMBL; CHEMBL2840; -. DR iPTMnet; P00860; -. DR PhosphoSitePlus; P00860; -. DR EPD; P00860; -. DR MaxQB; P00860; -. DR PaxDb; 10090-ENSMUSP00000128661; -. DR ProteomicsDB; 279314; -. DR Pumba; P00860; -. DR Antibodypedia; 781; 974 antibodies from 34 providers. DR DNASU; 18263; -. DR Ensembl; ENSMUST00000171737.3; ENSMUSP00000128661.2; ENSMUSG00000011179.9. DR GeneID; 18263; -. DR KEGG; mmu:18263; -. DR UCSC; uc007ncv.1; mouse. DR AGR; MGI:97402; -. DR CTD; 4953; -. DR MGI; MGI:97402; Odc1. DR VEuPathDB; HostDB:ENSMUSG00000011179; -. DR eggNOG; KOG0622; Eukaryota. DR GeneTree; ENSGT00950000182995; -. DR HOGENOM; CLU_026444_1_1_1; -. DR InParanoid; P00860; -. DR OMA; AYCRSMA; -. DR OrthoDB; 48358at2759; -. DR PhylomeDB; P00860; -. DR TreeFam; TF300760; -. DR BRENDA; 4.1.1.17; 3474. DR Reactome; R-MMU-350562; Regulation of ornithine decarboxylase (ODC). DR Reactome; R-MMU-351202; Metabolism of polyamines. DR SABIO-RK; P00860; -. DR UniPathway; UPA00535; UER00288. DR BioGRID-ORCS; 18263; 4 hits in 80 CRISPR screens. DR ChiTaRS; Odc1; mouse. DR EvolutionaryTrace; P00860; -. DR PRO; PR:P00860; -. DR Proteomes; UP000000589; Chromosome 12. DR RNAct; P00860; Protein. DR Bgee; ENSMUSG00000011179; Expressed in spermatid and 271 other cell types or tissues. DR ExpressionAtlas; P00860; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; IDA:MGI. DR GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI. DR GO; GO:0004586; F:ornithine decarboxylase activity; IDA:UniProtKB. DR GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB. DR GO; GO:0008283; P:cell population proliferation; IMP:MGI. DR GO; GO:0001822; P:kidney development; IMP:MGI. DR GO; GO:0006595; P:polyamine metabolic process; ISO:MGI. DR GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:MGI. DR GO; GO:0009446; P:putrescine biosynthetic process; ISO:MGI. DR GO; GO:0033387; P:putrescine biosynthetic process from ornithine; IDA:UniProtKB. DR GO; GO:0042176; P:regulation of protein catabolic process; IDA:UniProtKB. DR GO; GO:0009615; P:response to virus; IEA:Ensembl. DR CDD; cd00622; PLPDE_III_ODC; 1. DR Gene3D; 3.20.20.10; Alanine racemase; 1. DR InterPro; IPR009006; Ala_racemase/Decarboxylase_C. DR InterPro; IPR022643; De-COase2_C. DR InterPro; IPR022657; De-COase2_CS. DR InterPro; IPR022644; De-COase2_N. DR InterPro; IPR022653; De-COase2_pyr-phos_BS. DR InterPro; IPR000183; Orn/DAP/Arg_de-COase. DR InterPro; IPR002433; Orn_de-COase. DR InterPro; IPR029066; PLP-binding_barrel. DR PANTHER; PTHR11482; ARGININE/DIAMINOPIMELATE/ORNITHINE DECARBOXYLASE; 1. DR PANTHER; PTHR11482:SF42; ORNITHINE DECARBOXYLASE; 1. DR Pfam; PF02784; Orn_Arg_deC_N; 1. DR Pfam; PF00278; Orn_DAP_Arg_deC; 1. DR PRINTS; PR01179; ODADCRBXLASE. DR PRINTS; PR01182; ORNDCRBXLASE. DR SUPFAM; SSF50621; Alanine racemase C-terminal domain-like; 1. DR SUPFAM; SSF51419; PLP-binding barrel; 1. DR PROSITE; PS00878; ODR_DC_2_1; 1. DR PROSITE; PS00879; ODR_DC_2_2; 1. DR Genevisible; P00860; MM. PE 1: Evidence at protein level; KW 3D-structure; Decarboxylase; Lyase; Phosphoprotein; Polyamine biosynthesis; KW Pyridoxal phosphate; Reference proteome; S-nitrosylation. FT CHAIN 1..461 FT /note="Ornithine decarboxylase" FT /id="PRO_0000149892" FT ACT_SITE 360 FT /note="Proton donor; shared with dimeric partner" FT /evidence="ECO:0000269|PubMed:10378276, FT ECO:0000269|PubMed:1730582, ECO:0000269|PubMed:8504104" FT BINDING 200 FT /ligand="pyridoxal 5'-phosphate" FT /ligand_id="ChEBI:CHEBI:597326" FT /evidence="ECO:0000250|UniProtKB:P11926" FT BINDING 237 FT /ligand="pyridoxal 5'-phosphate" FT /ligand_id="ChEBI:CHEBI:597326" FT /evidence="ECO:0000269|PubMed:10378276" FT BINDING 274..277 FT /ligand="pyridoxal 5'-phosphate" FT /ligand_id="ChEBI:CHEBI:597326" FT /evidence="ECO:0000269|PubMed:10378276" FT BINDING 331..332 FT /ligand="substrate" FT /ligand_note="ligand shared between dimeric partners" FT /note="in other chain" FT /evidence="ECO:0000250|UniProtKB:P07805" FT BINDING 361 FT /ligand="substrate" FT /ligand_note="ligand shared between dimeric partners" FT /evidence="ECO:0000250|UniProtKB:P07805" FT BINDING 389 FT /ligand="pyridoxal 5'-phosphate" FT /ligand_id="ChEBI:CHEBI:597326" FT /evidence="ECO:0000269|PubMed:10378276" FT SITE 197 FT /note="Stacks against the aromatic ring of pyridoxal FT phosphate and stabilizes reaction intermediates" FT /evidence="ECO:0000305|PubMed:10378276" FT MOD_RES 69 FT /note="N6-(pyridoxal phosphate)lysine" FT /evidence="ECO:0000269|PubMed:10378276, FT ECO:0000269|PubMed:1730582, ECO:0007744|PDB:7ODC" FT MOD_RES 303 FT /note="Phosphoserine; by CK2" FT /evidence="ECO:0000269|PubMed:2026163" FT MOD_RES 360 FT /note="S-nitrosocysteine" FT /evidence="ECO:0000250|UniProtKB:P11926" FT MUTAGEN 387 FT /note="G->A: Partial loss of activity." FT /evidence="ECO:0000269|PubMed:8243470" FT MUTAGEN 387 FT /note="G->C,D,E,F,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y: Loss of FT activity." FT /evidence="ECO:0000269|PubMed:8243470" FT CONFLICT 178 FT /note="R -> W (in Ref. 10; AAA39846)" FT /evidence="ECO:0000305" FT CONFLICT 206 FT /note="E -> D (in Ref. 1; AAA51638, 2; AAA39845, 3; FT CAA30301, 4; AAA39849 and 5; AAB27809)" FT /evidence="ECO:0000305" FT CONFLICT 350 FT /note="Y -> H (in Ref. 10; AAA39848)" FT /evidence="ECO:0000305" FT STRAND 3..6 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 9..14 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 20..28 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 40..44 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 45..58 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 62..67 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 68..70 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 74..83 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 86..89 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 92..100 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 105..107 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 108..110 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 117..125 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 130..133 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 136..145 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 150..155 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 174..186 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 190..195 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 206..225 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 231..233 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 241..246 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 248..262 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 265..267 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 270..273 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 277..280 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 281..283 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 284..296 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 313..319 FT /evidence="ECO:0007829|PDB:7ODC" FT TURN 322..326 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 327..331 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 339..342 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 350..356 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 358..360 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 365..373 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 380..383 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 388..390 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 391..393 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 397..399 FT /evidence="ECO:0007829|PDB:7ODC" FT STRAND 404..410 FT /evidence="ECO:0007829|PDB:7ODC" FT HELIX 411..417 FT /evidence="ECO:0007829|PDB:7ODC" SQ SEQUENCE 461 AA; 51177 MW; B581753F57AC0A30 CRC64; MSSFTKDEFD CHILDEGFTA KDILDQKINE VSSSDDKDAF YVADLGDILK KHLRWLKALP RVTPFYAVKC NDSRAIVSTL AAIGTGFDCA SKTEIQLVQG LGVPAERVIY ANPCKQVSQI KYAASNGVQM MTFDSEIELM KVARAHPKAK LVLRIATDDS KAVCRLSVKF GATLKTSRLL LERAKELNID VIGVSFHVGS GCTDPETFVQ AVSDARCVFD MATEVGFSMH LLDIGGGFPG SEDTKLKFEE ITSVINPALD KYFPSDSGVR IIAEPGRYYV ASAFTLAVNI IAKKTVWKEQ PGSDDEDESN EQTFMYYVND GVYGSFNCIL YDHAHVKALL QKRPKPDEKY YSSSIWGPTC DGLDRIVERC NLPEMHVGDW MLFENMGAYT VAAASTFNGF QRPNIYYVMS RPMWQLMKQI QSHGFPPEVE EQDDGTLPMS CAQESGMDRH PAACASARIN V //